Injectable Nanoparticles Give Blind Retinas a Light Response
An international research team has developed microscopic particles that can make blind retinas respond to light. The particles behave as tiny, injectable light receptors. Once delivered into the eye, they settle close to nerve cells in the retina, and when light strikes them they trigger electrical and chemical processes that can activate those neurons and prompt them to send signals toward the brain.
The findings, published in Nature Biomedical Engineering, are preclinical: the evidence comes from experiments in blind mice and from retinal tissue taken from pigs. Even so, they mark a new chapter in a research effort that began at Aarhus University seven years ago with an ambitious question — whether a material could be built to serve as a wireless interface between light and living cells.
How the Particles Turn Light Into Nerve Signals
To appreciate the approach, it helps to start at the back of the eye. The retina is where light-sensitive photoreceptors normally capture incoming light and initiate the signals the brain uses to build vision. The nanoparticle strategy does not attempt to replace those cells. Instead, it gives the nerve cells that remain in the retina a new route for receiving light.
After injection, the particles come to rest near retinal nerve cells. When light hits them, a chain of electrical and chemical events follows, and those events are capable of switching the neurons on. Because the particles are activated by light itself and are delivered by injection rather than wired to an external power source, the team describes them as a wireless interface between light and living cells.
Calcium Release Reveals the Mechanism
Understanding how a particle converts light into biological activity requires watching cells closely. In one set of experiments, living cells took up the nanoparticles; when the particles were then exposed to blue light, the cells released calcium. Calcium plays an important role in cellular signaling, so its release served as a measurable readout of the particles' effect. The work helped the researchers understand how the nanoparticles translate light into activity that cells can respond to — a key step in explaining why the approach can drive neurons at all. Associate Professor Menglin Chen, at Aarhus University's Department of Biological and Chemical Engineering, studies precisely these interactions between light-sensitive particles and living cells.
What the Experiments Showed
Two lines of evidence anchor the study. In blind mice, the researchers were able to detect light-induced signals in the visual cortex, the brain region that processes visual information. The animals also displayed behavioral responses to light — a sign that the signal was not merely present but meaningful to the animal. Separately, the team showed that the technology can activate nerve cells in retinal tissue from pigs, indicating the effect is not confined to a single species.
- Light-induced signals were detected in the visual cortex of blind mice.
- Blind mice showed behavioral responses to light.
- Nerve cells in pig retinal tissue were activated by the technology.
- The particles act as injectable, light-driven receptors rather than wired implants.
Read together, the results trace a path from light entering the eye, to activation of retinal neurons, to a detectable response in the brain.
A Seven-Year Project Built on a Simple Question
The study is the latest chapter in a program that began at Aarhus University seven years ago. The founding idea was deliberately ambitious: could researchers develop a kind of microscopic "solar cell" that could be placed inside the body and use light to control cellular activity? That framing captures the essential trick — a material that harvests light and converts it into a form of energy that biology can use.
Chen describes the original motivation as a fundamental question about whether it was possible to create a material that could act as a wireless interface between light and living cells. The new results, she notes, show that the particles are able to activate nerve cells in blind retinas, which brings the team closer to its long-term goal of developing a new type of retinal prosthesis.
Why a New Type of Retinal Prosthesis Matters
The long-term target is a prosthetic approach to vision that relies on light-sensitive particles rather than a fixed piece of hardware. Because the particles are injected and switched on by light, the concept points toward a retinal prosthesis that is wireless by design. For retinas that have lost their light-sensing cells but retain the nerve cells downstream of them, the appeal is straightforward: the particles supply the missing light-detection function, and the retina's own circuitry carries the signal onward.
What Remains to Be Shown
Important caveats come with these results. The study is preclinical, and its evidence comes from blind mice and from pig retinal tissue rather than from human patients. Whether the approach can eventually be translated into usable vision in people — and how stable, safe and durable the particles would prove over the long term inside a living eye — are questions that only further research and clinical testing can answer.
What the current work does establish is a proof of principle: the particles made blind retinas respond to light, and that response traveled far enough to register in the brain.
The Bottom Line
A seven-year effort to build a microscopic light-to-cell interface has produced injectable nanoparticles that restore a light response in blind retinas. In mice, the resulting signals reached the visual cortex and changed behavior; in pig tissue, retinal neurons were activated. The researchers position the advance as a step toward a new class of retinal prosthesis, with the technology still at the preclinical stage.
This article is based on reporting by Phys.org. Read the original article.
Originally published on phys.org
